| Description | Rulonilimab, a human IgG1 monoclonal antibody, targets and binds to PD-1, inhibiting its downstream signaling pathways. This action potentially enables immune checkpoint inhibition and exhibits anti-tumor activity [1]. |
| molecular weight | N/A |
| CAS | 2417124-95-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |